Pharma must collaborate to survive "brave new world" of 2020
This article was originally published in Scrip
Executive Summary
Pharmaceutical companies must collaborate in the face of a "do or die" scenario in 2020, a new report has found. The consultancy group PricewaterhouseCoopers warns that leading firms will be leapfrogged by competitors in other sectors if they do not revise their business models rapidly.